Bayesian Meta-Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
From MaRDI portal
Publication:2912356
DOI10.1111/j.1541-0420.2011.01679.xzbMath1274.62795OpenAlexW2115067514WikidataQ41867314 ScholiaQ41867314MaRDI QIDQ2912356
No author found.
Publication date: 14 September 2012
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3571108
Related Items
Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome, Normalized power prior Bayesian analysis, Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials
Cites Work
- Bayesian Design of Noninferiority Trials for Medical Devices Using Historical Data
- Bayesianly justifiable and relevant frequency calculations for the applied statistician
- A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models
- Bayesian sample size determination for binomial proportions
- Sampling and Bayes' Inference in Scientific Modelling and Robustness
- Bayesian survival analysis
